article thumbnail

Hospital, health system boards saw low turnover, slow diversity gains from 2018-2022, AHA finds

Fierce Healthcare

Hospital, health system boards saw low turnover, slow diversity gains from 2018-2022, AHA finds dmuoio Tue, 01/24/2023 - 10:23

Hospitals 109
article thumbnail

340B program reaches $100 billion in sales, while patients are left behind

PhRMA

year-over-year in 2022, continuing a trend in which 340B sales have almost doubled since 2018, outpacing growth of the total U.S. The 340B Drug Pricing Program has grown yet again , exceeding $100 billion in sales in 2022 when 340B-priced medicines are measured at wholesale acquisition cost. Recent data from IQVIA shows 340B grew 12.2%

261
261
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Rite Aid Addresses Cyberattack: 2.2 Million Customers’ Data Breached

Drug Topics

The retail pharmacy chain issued an alert to its customers that purchasing data from 2017 to 2018 may have been breached by a third party.

209
209
article thumbnail

Over twice as many healthcare workers report harassment in 2022 than 2018, CDC finds

Fierce Healthcare

New survey data from the Centers for Disease Control and Prevention (CDC) is reinforcing doctors’ warnings that the medical field is crumbling under a largely unaddressed mental health crisis and a | Survey data outlining healthcare workers' worsening mental health and workplace difficulties comes alongside new calls for action from the CDC and (..)

124
124
article thumbnail

Type 2 Diabetes in Young Patients Spiked in Year 1 of COVID-19 Pandemic

Drug Topics

Using electronic medical record data from 2018-2020 obtained from 24 medical centers across the US, including Johns Hopkins, University of Colorado, and Mayo Clinic institutions, a new study suggests rates of youth onset type 2 diabetes increased 77% during the first year of the pandemic.

article thumbnail

Eli Lilly agrees to provide free and lower-priced insulin in Minnesota to resolve 2018 lawsuit

Fierce Pharma

After reaching a settlement with Minnesota’s attorney general, Eli Lilly can close the book on a yearslong lawsuit in the state. | The company will provide its insulin products at $35 per month and donate free insulin at 15 clinics over the next five years. Meanwhile, Minnesota's claims against Novo Nordisk and Sanofi remain ongoing.

98
article thumbnail

Study: The Pandemic Disrupted Children’s Readiness for Kindergarten

Pharmacy Times

Between 2018 and 2021, kindergarten-readiness dropped by 10%.

139
139